Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors

Aromatase (CYP19) is a critical enzyme for estrogen biosynthesis, and aromatase inhibitors (AIs) are established endocrine therapy for post-menopausal women with breast cancer. DNA samples were obtained from 52 women pre- and post-AI treatment in the neoadjuvant setting. 82 breast cancer and 19 norm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Liewei, Ellsworth, Katarzyna A., Moon, Irene, Pelleymounter, Linda L., Eckloff, Bruce W., Martin, Yvette N., Fridley, Brooke L., Jenkins, Gregory D., Batzler, Anthony, Suman, Vera J., Ravi, Saranya, Dixon, J. Michael, Miller, William R., Wieben, Eric D., Buzdar, Aman, M.Weinshilboum, Richard, Ingle, James N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2804935/
https://ncbi.nlm.nih.gov/pubmed/20048079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-3224
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados